Literature DB >> 14503018

Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in rats.

J C de la Torre1, B A Pappas, V Prevot, M R Emmerling, K Mantione, T Fortin, M D Watson, G B Stefano.   

Abstract

Chronic brain hypoperfusion (CBH) using permanent occlusion of both common carotid arteries in an aging rat model, has been shown to mimic human mild cognitive impairment (MCI), an acknowledged high risk condition that often converts to Alzheimer's disease. An aging rat model was used to determine whether hippocampal nitric oxide (NO) is abnormally expressed following CBH for two or eight weeks. At each time point, spatial memory was measured with the Morris water maze and hippocampal A beta 1-40/1-42 concentrations were obtained using sandwich ELISA. Real-time amperometric measures of NO representing the constitutive isoforms of neuronal nitric oxide synthase (nNOS) and endothelial (e)NOS were also taken at each time point to ascertain whether NO levels changed as a result of CBH, and if so, whether such NO changes preceded or followed any memory or amyloid-beta pathology. We found that two weeks after CBH, NO hippocampal levels were upregulated nearly four-fold when compared to nonoccluded rats but no alteration in spatial memory of A beta products were observed at this time point. By contrast, NO concentration had declined to control levels by eight weeks but spatial memory was found significantly impaired and A beta 1-40 (but not A beta 1-42) had increased in the CBH group when compared to control rats. Since changes in shear stress are known to upregulate eNOS but generally not nNOS, these results suggest that shear stress induced by CBH hyperactivated vascular NO derived from eNOS in the first two weeks as a reaction by the capillary endothelium to maintain homeostasis of local cerebral blood flow. The return of vascular NO to basal levels after eight weeks of CBH may have triggered metabolic changes within hippocampal cells resulting in hippocampal dysfunction as reflected by spatial memory impairment and by accumulation of A beta 1-40 peptide. In conclusion, our study shows that CBH initiates spatial memory loss in aging rats thus mimicking human MCI and also increases A beta 1-40 in the hippocampus. The memory and amyloid changes are preceded by NO upregulation in the hippocampus. These preliminary findings may be important in understanding, at least in part, the molecular mechanisms that precede memory impairment during chronic brain ischemia and as such, the pre-clinical stage leading to Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14503018     DOI: 10.1179/016164103101201931

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  25 in total

1.  Double-Edged Roles of Nitric Oxide Signaling on APP Processing and Amyloid-β Production In Vitro: Preliminary Evidence from Sodium Nitroprusside.

Authors:  Zheng-Xu Cai; Hui-Shu Guo; Che Wang; Min Wei; Cheng Cheng; Zhao-Fei Yang; Yin-Wang Chen; Wei-Dong Le; Song Li
Journal:  Neurotox Res       Date:  2015-10-01       Impact factor: 3.911

2.  S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Balasubramaniam Annamalai; Seungho Choi; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-08-10       Impact factor: 3.252

3.  Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition.

Authors:  Bryan D Devan; Jonna L Bowker; Kara B Duffy; Ila S Bharati; Mariana Jimenez; Demetrio Sierra-Mercado; Christopher M Nelson; Edward L Spangler; Donald K Ingram
Journal:  Psychopharmacology (Berl)       Date:  2005-11-18       Impact factor: 4.530

4.  Chronic Cerebral Hypoperfusion Induced Synaptic Proteome Changes in the rat Cerebral Cortex.

Authors:  Katalin Völgyi; Péter Gulyássy; Mihail Ivilinov Todorov; Gina Puska; Kata Badics; Dávid Hlatky; Katalin Adrienna Kékesi; Gabriella Nyitrai; András Czurkó; László Drahos; Arpád Dobolyi
Journal:  Mol Neurobiol       Date:  2017-06-15       Impact factor: 5.590

5.  Clinical predictors of cognitive decline in patients with mild cognitive impairment: the Chongqing aging study.

Authors:  Ling Li; Yanjiang Wang; Jiachuan Yan; Yang Chen; Rui Zhou; Xu Yi; Qianqian Shi; Huadong Zhou
Journal:  J Neurol       Date:  2011-12-21       Impact factor: 4.849

Review 6.  NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism.

Authors:  Bernardo Moreno-López; Carmen R Sunico; David González-Forero
Journal:  Mol Neurobiol       Date:  2010-12-29       Impact factor: 5.590

7.  Flavanols, mild cognitive impairment, and Alzheimer's dementia.

Authors:  Ami K Patel; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2008-04-15

8.  Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Jinsu Kim; Balasubramaniam Annamalai; Anandakumar Shunmugavel; Inderjit Singh; Avtar K Singh
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments.

Authors:  Abbas K Ali; William A Banks; Vijaya B Kumar; Gul N Shah; Jessica L Lynch; Susan A Farr; Melissa A Fleegal-DeMotta; John E Morley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-06-16       Impact factor: 6.053

10.  Expression of Tau protein in rats with cognitive dysfunction induced by cerebral hypoperfusion.

Authors:  Ji-Feng Li; Zhou Wang; Qin-Jian Sun; Yi-Feng Du
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.